A retrospective analysis of selected patients with glioblastoma who received treatment for cytomegalovirus with their anticancer treatment showed surprisingly good 2-year survival. A randomized trial is needed.
No takes yet. Share an insight, caveat, or question.
Söderberg‐Nauclér et al. (2013) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: